Sodium Salicylate

水杨酸钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSodium Salicylate
Drug Alias Name水扬酸钠柳酸钠
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainFeverInflammation +[8] 
Global Approved IndicationsPainFeverInflammation +[5] 
Approved Indications in ChinaPainFeverInflammation +[4] 
Original Approved Country/TerritoryCanada
Original Approved Date1920/01/01
Country/TerritoryCanadaUnited StatesMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGrand Pharmaceutical （China） Co Ltd
Inactive CompaniesNational Cancer Institute
Active IndicationsPainFeverInflammation +[5] 
Inactive IndicationsMyelodysplastic SyndromesMyelodysplastic-Myeloproliferative DiseasesLeukemia

Other Information

ATC CodeN02BA04
Related LinksWikipediaKEGG